Twitter: @jockinmikeg
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NAII: a bit more clarity on the overhang may restore some investor confidence. Because of the insider selling, sentiment seems low on this one, and is reflected in the bearish chart. If $10.50 double bottom breaks support, this could get inexplicably cheaper. Thanks for the opinion on earnings. Good numbers may be enough to attract some buying, chew through some of this overhang, and get us to a more appropriate valuation.
NAII: filings show Borg has been selling quite methodically, but I guess the question is why? Stock seems cheap here, and I bought a starter, but committed to staying small in case $10.50 falls or we get more clarity on earnings or the insider sales.
Now I do agree with you on those points. I'll keep it topic related, and I hope patient shareholders win. It's just slow here as investors ponder whether the company hears an update on the FDA application or deal news before the next cash raise.
Brook, the rise and fall of XXII and the importance of smart trading was the analogy I was trying to draw in my posts, while not directly related, lends credence.
Lnp is a good guy. He is real about his investment here, and I think his eyes are wide open. So I disagree with you there.
Just my opinion of course, but my experience has shown that fear of missed profits ends up in selling too late. Why don't you sell half and ride free shares?
Sounds like greed kicking in. Remember the XXII story.
$XXII: a plant biotech recently covered by Sheff, saw a write up on current litigation:
http://www.gurufocus.com/news/429264/all-you-need-to-know-about-crede-capital-vs-22nd-century-group-
Crede vs XXII: as a follow up, here is the link to your transcript
http://www.gurufocus.com/news/429264/all-you-need-to-know-about-crede-capital-vs-22nd-century-group-
You're a bit light on that OS. I don't keep up much but last count showed roughly 78-80M
Impressive list of microcaps, a few of which I own myself. Good luck to us!
KOSS interesting AH activity. Maybe news coming.
Another huge seller at 1.43.
Clear that and I think it could run. The volume is telling.
FCHS r/g on over 5x average volume. Doubled my position at a dollar today. They added two new doctors recently, and as a result increased their Q4 estimates. Analysts released a coverage update last month:
http://s1.q4cdn.com/460208960/files/News/2016/June-15-2016_FCHS_Gilson.pdf?utm_content=bufferb3a68&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
FCHS r/g on heavy volume. Picked up several shares today at a dollar.
And it's gone. Huge volume today. Still holding. Let's see if there is any heavy selling left.
Someone just ate a huge chunk of that 80k!
Sheff, a popular I-Hub biotech trader with a pretty decent following, bought in here today. Hence the reason for the pop. Problem is, when he sells, his sheep often follow.
Interested to see how many he's really trying to sell. If you buy at the ask, he may back off.
EVOL: thanks for the mention on this one. I was lucky to buy in near $5, and as you remember had some problems getting shares via TDA without going thru a broker at the trade desk. Just yesterday I called and they told me the symbol has been "updated" so I can finally place orders myself. I remember others having a similar issue buying EVOL at first, but it appears to be resolved. Solid company, crappy stock, nice yield. I hope they don't reduce their dividend, but if revenues are what we guess them to be, stock is still a bargain IMO .
Nice day EVOL. Bought in around $5 and averaging up
If you slap that ask for 80,000 shares, you are the man.
EVOL squeezing.
Yeah that's not an effective way to sell.
A few million and we would clear the 6s. Time to call your friends.
Need some of your new friends in on these prices. Most longs here are tapped out to support the bid.
Heavy volume today. I added to my position. Hard to shake shares loose on this one.
I picked up some $1.36s. The website looks great, and clearly explains the applications of each subsidiary. Their commitment to research may necessitate a cash raise in the future, but it's a necessary evil since their industry requires the need to innovate in order to stay competitive. Long term I think this is an interesting play. Heavy relative volume today.
SVTE up 40% - momo crowd likely with more volume and awareness. Not selling a share.
SVTE looking thin here. One little slap on the ask could clear those 5's. Someone pony up. I've been adding.
SVTE: these guys must put out full releases that hit all the wires when they have news. Do I really have to explain to the CEO that more eyeballs = more people buying his POS stock?
Lesson learned on newsletter stocks: trade them, don't marry them. When the herd is buying, you better be selling. Sorry to all the good folks here who invested hard earned money and lost tons.
SVTE: sub-pennies move on news, and next couple weeks should be interesting.
Good to hear. I like the SS and the record growth. The float is so small for a sub-penny, it wouldn't take much for a small group to push this stock way up. I have seen much bigger turds with bloated SS run up 100-200% on nothing. Some good traders here. Good luck if you choose to get in.
I saw some bids lurking down below today, 3M and 1M in the .003s, so either someone is window dressing or trying to hop in big for cheap.
We need some RX diehards to pick up on this play. New money is needed.
SVTE: no buyers yet no sellers.
Everyone tapped out?
550,000 shares diluted so far since the last O/S increase @ .0044 = $2420.
If you have any rich friends, call them up. Plenty of stock for sale. Love the revenues, but SVTE has got to show profitability hitting the bottom line so the pps doesn't get continue to be whipsawed by more issued shares.
Do you talk to the CEO? You own a ton of shares. What's his take?
CEO follow up is crucial to plays like this. Investor days don't hurt. Some new money wouldn't hurt either.
Deal news with strong dollar figure or that newly issued shares bleed will stop could serve a nice run-up.